Although sialylation in the TKI-resistant mutants suppresses EGFR tyrosine phosphorylation with the most significant effect on the Y1173 site, the sialylation effect was not strong enough to stop cancer progression by inhibiting the phosphorylation of these three sites. The gene discussed is EGFR; the disease is cancer.